Terms: = Ovarian cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Diagnosis
13 results:
1. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
[TBL] [Abstract] [Full Text] [Related]
2. The association of macronutrient quality and its interactions with energy intake with survival among patients with ovarian cancer: results from a prospective cohort study.
Zheng G; Gong TT; Ma QP; Wei YF; Du ZD; Zhao JQ; Zou BJ; Yan S; Liu FH; Sun ML; Xiao Q; Gao S; Wu QJ; Zhao YH
Am J Clin Nutr; 2023 Jun; 117(6):1362-1371. PubMed ID: 37001589
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Biomarkers for ovarian cancer diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
Zheng Q; Ye H; Zhong H; Wang M
Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
[TBL] [Abstract] [Full Text] [Related]
4. Identification of core genes for early diagnosis and the EMT modulation of ovarian serous cancer by bioinformatics perspective.
Zhang Y; Wang X; Chen X
Aging (Albany NY); 2021 Jan; 13(2):3112-3145. PubMed ID: 33493131
[TBL] [Abstract] [Full Text] [Related]
5. Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study.
Majidi A; Na R; Jordan SJ; De Fazio A; Webb PM;
Int J Cancer; 2021 Apr; 148(7):1608-1615. PubMed ID: 33034053
[TBL] [Abstract] [Full Text] [Related]
6. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract] [Full Text] [Related]
7. Clusterin immunoexpression is associated with early stage endometrial carcinomas.
Al-Maghrabi JA; Butt NS; Anfinan N; Sait K; Sait H; Bajouh O; Khabaz MN
Acta Histochem; 2016 May; 118(4):430-4. PubMed ID: 27079858
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.
van Kruchten M; de Vries EF; Arts HJ; Jager NM; Bongaerts AH; Glaudemans AW; Hollema H; de Vries EG; Hospers GA; Reyners AK
J Nucl Med; 2015 Jan; 56(1):50-5. PubMed ID: 25476534
[TBL] [Abstract] [Full Text] [Related]
9. Urinary concentrations of human epidydimis secretory protein 4 (He4) in the diagnosis of ovarian cancer: a case--control study.
Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(9):4695-8. PubMed ID: 23167404
[TBL] [Abstract] [Full Text] [Related]
10. Pathway-based classification of cancer subtypes.
Kim S; Kon M; DeLisi C
Biol Direct; 2012 Jul; 7():21. PubMed ID: 22759382
[TBL] [Abstract] [Full Text] [Related]
11. Genetic testing in young women with breast cancer: results from a Web-based survey.
Ruddy KJ; Gelber S; Shin J; Garber JE; Rosenberg R; Przypysny M; Partridge AH
Ann Oncol; 2010 Apr; 21(4):741-747. PubMed ID: 19713245
[TBL] [Abstract] [Full Text] [Related]
12. BACH1 Ser919Pro variant and breast cancer risk.
Vahteristo P; Yliannala K; Tamminen A; Eerola H; Blomqvist C; Nevanlinna H
BMC Cancer; 2006 Jan; 6():19. PubMed ID: 16430786
[TBL] [Abstract] [Full Text] [Related]
13. The radiosensitivity of the human oocyte.
Wallace WH; Thomson AB; Kelsey TW
Hum Reprod; 2003 Jan; 18(1):117-21. PubMed ID: 12525451
[TBL] [Abstract] [Full Text] [Related]
